Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01298804 · ClinicalTrials.gov registry record · NA

Preventing Maternal Depression In Head Start

A NA study of Depression, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
230
Enrollment target
2
Study locations

NCT01298804: Completed NA study of Depression, sponsored by Boston Medical Center.

NCT01298804 is a NA study of Depression that has completed, run by Boston Medical Center. The registered enrollment target is 230 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01298804, a NA study of Depression, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
230 participants
Enrollment target
2
Study locations

Study Summary

Maternal depression disproportionately affects low-income and minority women, and has profound negative impacts on their children. The investigators are conducting a randomized trial of a systems approach to identify mothers at risk for depression in Head Start - a federally funded early learning program for children of low-income families - and to provide an on-site intervention to prevent or alleviate depressive symptoms; improve functioning; and, where appropriate, proactively link mothers to more definitive mental health services.

Primary Outcome

QIDS

Conditions Studied

Interventions

  • BEHAVIORAL Problem Solving Education and Activated Referral to Care

Study Locations (2)

Massachusetts

  • ABCD Head Start - Boston
  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2011-02
Est. Completion 2016-07
Phase NA
Boston Medical Center

253 total trials

What the finished NCT01298804 record still lists

NCT01298804 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Problem Solving Education and Activated Referral to Care is the first listed.

NCT01298804 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01298804 about?

NCT01298804 is a clinical study titled "Preventing Maternal Depression In Head Start". Maternal depression disproportionately affects low-income and minority women, and has profound negative impacts on their children. The investigators are conducting a randomized trial of a systems approach to identify mothers at risk for depression in Head Start - a federally funded early learning pr...

What is the current status of trial NCT01298804?

This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2011-02. Estimated completion is 2016-07.

What conditions does trial NCT01298804 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT01298804?

The interventions under investigation include: Problem Solving Education and Activated Referral to Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01298804?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01298804 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01298804's enrollment target sits among peer trials

230 190th of 679 higher than 489 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01298804, the US trial registry maintained by the National Library of Medicine. NCT01298804 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.